These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8741668)

  • 1. [Fas antigen expression on human hematopoietic progenitor cells].
    Nagafuji K; Takenaka K; Niho Y
    Nihon Rinsho; 1996 Jul; 54(7):1790-6. PubMed ID: 8741668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas antigen (CD95) and hematopoietic progenitor cells.
    Nagafuji K; Takenaka K; Shibuya T; Harada M; Niho Y
    Leuk Lymphoma; 1996 Dec; 24(1-2):43-56. PubMed ID: 9049961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells.
    Nagafuji K; Shibuya T; Harada M; Mizuno S; Takenaka K; Miyamoto T; Okamura T; Gondo H; Niho Y
    Blood; 1995 Aug; 86(3):883-9. PubMed ID: 7542501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.
    Maciejewski J; Selleri C; Anderson S; Young NS
    Blood; 1995 Jun; 85(11):3183-90. PubMed ID: 7538820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells.
    Sato T; Selleri C; Anderson S; Young NS; Maciejewski JP
    Br J Haematol; 1997 May; 97(2):356-65. PubMed ID: 9163602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and function of CD95/fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells].
    Ma YP; Zhou P; Xiao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):13-6. PubMed ID: 12513829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
    Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34+ bone marrow progenitor cells from aplastic anemia patients and normal donors.
    Welsh JP; Rutherford TR; Flynn J; Foukaneli T; Gordon-Smith EC; Gibson FM
    Hematol J; 2004; 5(1):39-46. PubMed ID: 14745429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95).
    Takenaka K; Nagafuji K; Harada M; Mizuno S; Miyamoto T; Makino S; Gondo H; Okamura T; Niho Y
    Blood; 1996 Oct; 88(8):2871-7. PubMed ID: 8874183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential.
    Sloand EM; Young NS; Sato T; Kim S; Maciejewski JP
    Exp Hematol; 1998 Oct; 26(11):1093-9. PubMed ID: 9766451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
    Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F
    Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional expression of CD95/Fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells.
    Ma Y; Zou P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):24-7. PubMed ID: 12658775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.
    Maurillo L; Del Poeta G; Venditti A; Buccisano F; Battaglia A; Santinelli S; Caravita T; Epiceno AM; Del Moro B; Tamburini A; Picardi A; Suppo G; Catalano G; Bruno A; Amadori S
    Haematologica; 2001 Mar; 86(3):237-43. PubMed ID: 11255269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
    Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
    Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia.
    Maciejewski JP; Selleri C; Sato T; Anderson S; Young NS
    Br J Haematol; 1995 Sep; 91(1):245-52. PubMed ID: 7577642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas antigen (CD95) expression in peripheral blood progenitor cells from patients with leukaemia and lymphoma.
    Anthony RS; Mckelvie ND; Craig JI; Parker AC
    Leuk Lymphoma; 1998 Aug; 30(5-6):449-58. PubMed ID: 9711907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A probable role for trail-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients.
    Kakagianni T; Giannakoulas NC; Thanopoulou E; Galani A; Michalopoulou S; Kouraklis-Symeonidis A; Zoumbos NC
    Leuk Res; 2006 Jun; 30(6):713-21. PubMed ID: 16310248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
    Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
    J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
    Selleri C; Maciejewski JP; Catalano L; Ricci P; Andretta C; Luciano L; Rotoli B
    Cancer; 2002 Nov; 95(9):1911-22. PubMed ID: 12404285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
    Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.